Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

698.79
+9.201.33%
Number of Gainers:82
Number of Losers:64
Number of Flat:8
PE:- -
High:700.84
Open:690.16
Low:683.51
Close:689.59
Volume:305.48M
Turnover:8.27B
Market Cap:488.56B
Float Cap:370.49B

Loading ...

Major Insider Move at CAMP4 Therapeutics Shakes Up Investor Buzz

TIPRANKS
·
Aug 22

Karat Packaging VP-Manufacturing Marvin Cheng Reports Disposal of 4,500 Common Shares Worth $212,985

Reuters
·
Aug 22

Robinhood Stock And 2 Cash Yield Plays Investors Are Watching As Treasury Yields Rise

Simply Wall St.
·
Aug 22

Coca Cola Stock And 2 Consumer Staples Dividend Picks For Tougher Times

Simply Wall St.
·
Aug 22

LegalZoom COO, CFO Noel Bertram Watson Sells 500,000 Shares Worth $2,949,893.46

Reuters
·
Aug 22

Riskified Director Shachar Erez Disposes of USD 1.78 Million in Common Shares

Reuters
·
Aug 22

ETF Daily | CRMU Soars 47%; HOOX, HODU Jump 27%; NUGT Climbs 6%; HOOZ Slides 27%; Materials And Uranium Lead

ETF Tracker
·
Aug 22

Option Focus | Coinbase's $2 Million Bull Call Spread Targets $230–$310 by 2026, but $1.77 Million Bear Put Spread and Net Bearish Flow Reveal Defensive Undertow

Option Witch
·
Aug 22

ZipRecruiter EVP, CFO Carmen Wai-Yan Chan Files Initial Beneficial Ownership Statement

Reuters
·
Aug 22

ZipRecruiter EVP, Chief People Officer Amy Garefis Disposes of 7,819 Shares Worth $40,297.41

Reuters
·
Aug 22

NASD Most Active Issues

Dow Jones
·
Aug 22

Exchange Traded Funds Top 10 Percentage Gainers

Dow Jones
·
Aug 22

AuthID Receives Nasdaq Deficiency Notice on Equity Levels

TIPRANKS
·
Aug 22

AuthID Receives NASDAQ Notice for Failing to Meet $2.5 Million Stockholders’ Equity Rule

Reuters
·
Aug 22

Silexion Therapeutics Receives Nasdaq Delisting Notice, Plans Appeal

TIPRANKS
·
Aug 22

Tempest Therapeutics files to sell 8.91M shares of common stock for holders

TIPRANKS
·
Aug 22

Alzamend Neuro - Files to Register Resale of up to 98.4 Mln Common Shares by Selling Stockholder - SEC Filing

THOMSON REUTERS
·
Aug 22

Cytek Biosciences: Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; to Challenge Remaining Finding

THOMSON REUTERS
·
Aug 22

Cytek Biosciences: Jury Awarded Past Damages Consisting of $20 Mln in Lost Profits and $36 Mln in Royalties

THOMSON REUTERS
·
Aug 22

US Equity Markets End Higher After Iran Hints at Desire to End War Soon, Crude Oil Prices Halt

MT Newswires Live
·
Aug 22